Impurity reference standards
Lazertinib impurities & reference standards
Characterised Lazertinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
9reference materials
1nitrosamine impurities
COAHPLC · NMR · MS on request
Parent API: Lazertinib
1903008-80-9 · C30H34N8O3
N-(5-((4-(4-Formyl-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide
- CAS
- 2270204-98-1
- Formula
- C23H25N7O4
- MW
- 463.5 g/mol
VQ-037915
FAQs — Lazertinib impurities
Which Lazertinib impurities do you supply?
We list 9 Lazertinib-related reference materials, including process impurities, degradation products, nitrosamine impurities and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Lazertinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Lazertinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Lazertinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.